This report should not be construed as providing investment advice. It is for educational purposes only.  Before making any investment decision, you should always do your own research or consult a investment professional.
While I try to be accurate, I assume no responsibility for any figure in this spreadsheet.
See my website on stocks or see my blog at the following sites.  www.spbrunner.com/stocks.html www.spbrunner.blogspot.com/
Brookfield Office Properties TSX: BPO www.brookfieldofficeproperties.com Fiscal Yr: Dec 31 NYSE: BPO
Year 12/31/99 12/31/00 12/31/01 12/31/02 12/31/03 12/31/04 12/31/05 12/31/06 12/31/07 12/31/08 12/31/09 12/31/10 12/31/11 12/30/12 #Y
Accting Rules IFRS IFRS IFRS
Split 1.5 1.5
Rep. Currency CND$ US$ US$ US$ US$ US$ US$ US$ US$ US$ US$ US$ US$ US$
USD - CDN$ 1.4733 1.5224 1.5926 1.5796 1.2924 1.2048 1.1630 1.1652 0.9881 1.2240 1.0501 0.9970 0.9970 0.9970 USD - CDN$
Revenue US$ $1,846.9 $2,100.0 $2,280.0 $1,372.0 $1,363.0 $1,442.0 $1,549.0 $1,911.0 $2,912.0 $2,805.0 $2,676.0 $1,326.0 $2,065.0 $2,161.0 -36.86% <-Total Growth 10 Revenues US$
Rev per Share $6.19 $5.88 $6.27 $3.80 $3.88 $4.12 $4.47 $4.81 $7.41 $7.17 $5.34 $2.64 $4.10 $4.29 -4.49% <-IRR #YR-> 10 Revenues US$
Increase 20.88% -4.96% 6.60% -39.33% 1.96% 6.24% 8.44% 7.80% 53.97% -3.26% -25.58% -50.58% 55.42% 4.65% -3.06% <-IRR #YR-> 5 Revenues US$
P/S (Price/Sales) 0.75 1.33 1.22 2.36 3.29 4.10 4.39 5.45 2.60 1.08 2.27 6.65 4.05 3.87 -7.70% <-IRR #YR-> 10 RevPer share US$
*Revenue in M US$  P/S 10 yr  2.94 5 yr  2.60 -10.00% <-IRR #YR-> 5 RevPer share US$
Revenue* $2,721.0 $3,197.0 $3,631.1 $2,167.2 $1,761.5 $1,737.3 $1,801.5 $2,226.7 $2,877.3 $3,433.3 $2,810.1 $1,322.0 $2,058.8 $2,154.5 -58.65% <-Total Growth 10 Revenues CND$
Increase 15.15% 17.50% 13.58% -40.32% -18.72% -1.37% 3.69% 23.60% 29.22% 19.32% -18.15% -52.95% 55.73% 4.65% -8.45% <-IRR #YR-> 10 Revenues CND$
Rev per Share $9.11 $8.95 $9.98 $6.01 $5.01 $4.96 $5.19 $5.61 $7.33 $8.78 $5.60 $2.63 $4.09 $4.28 -6.00% <-IRR #YR-> 5 Revenues CND$
Increase 15.48% -1.79% 11.52% -39.83% -16.58% -0.97% 4.68% 8.01% 30.57% 19.84% -36.15% -53.08% 55.42% 4.65% -11.53% <-IRR #YR-> 10 RevPer share CND$
P/S (Price/Sales) 0.90 1.31 1.24 2.11 3.30 4.02 4.47 5.34 2.62 1.06 2.28 6.68 3.98 3.80 -12.73% <-IRR #YR-> 5 RevPer share CND$
*Revenue in M CDN $  P/S 10 yr  2.96 5 yr  2.62
-$3,197 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $1,322
-$1,801 $0.0 $0.0 $0.0 $0.0 $1,322
-$8.95 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.63
-$5.19 $0.00 $0.00 $0.00 $0.00 $2.63
EPS US$ $0.38 $0.42 $0.60 $0.72 $0.72 $0.39 $0.46 $0.37 $0.59 $1.77 $0.72 $2.73 $1.75 $1.26 493.48% <-Total Growth 5 Earnings US$
EPS* $0.56 $0.64 $0.96 $1.13 $0.94 $0.47 $0.53 $0.43 $0.58 $2.17 $0.76 $2.72 $1.74 $1.26 323.44% <-Total Growth 10 Earnings CND$
Increase 21.15% 14.78% 49.76% 17.42% -17.17% -50.24% 14.84% -19.41% 35.22% 271.62% -65.10% 259.99% -35.90% -28.00% 15.53% <-IRR #YR-> 10 Earnings CND$
Earnings Yield 6.8% 5.5% 7.8% 8.9% 5.7% 2.3% 2.3% 1.4% 3.0% 23.3% 5.9% 15.5% 10.7% 7.7% 38.45% <-IRR #YR-> 5 Earnings CND$
* ESP per share (Cdn GAAP) E/P 10 Yrs 5.78% 5Yrs 5.91%
-$0.64 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $2.72
-$0.53 $0.00 $0.00 $0.00 $0.00 $2.72
Div  pre 05 $0.32 $0.25 $0.33 $0.40 $0.50 $0.62 Dividends US$
Div  pre 07 $0.21 $0.17 $0.22 $0.27 $0.33 $0.41 Dividends US$
Div US$ $0.11 $0.15 $0.18 $0.22 $0.28 $0.43 $0.51 $0.55 $0.56 $0.56 $0.56 $0.56 $0.56 30.23% <-Total Growth 5 Dividends US$
Increase 32.00% 21.21% 25.00% 24.00% 56.05% 18.60% 7.84% 1.82% 0.00% 0.00% 0.00% 0.00% Dividends US$
Div* $0.14 $0.17 $0.23 $0.28 $0.29 $0.33 $0.50 $0.59 $0.54 $0.69 $0.59 $0.56 $0.56 $0.56 230.07% <-Total Growth 10 Dividends CND$
Increase 33.33% 18.94% 38.09% 20.22% 2.27% 15.60% 50.63% 18.83% -8.55% 26.13% -14.21% -5.06% 0.00% 0.00% 17.21% <-Median-> 10 Dividends CND$
Yield H/L 1.77% 1.84% 1.94% 2.15% 2.00% 1.84% 2.30% 2.23% 1.93% 4.58% 6.10% 3.57% 2.19% <-Median-> 10 Dividends CND$
Yield on High 1.45% 1.40% 1.70% 1.98% 1.73% 1.66% 2.09% 1.93% 1.47% 2.97% 4.36% 2.98% 1.95% <-Median-> 10 Dividends CND$
Yield on Low 2.25% 2.71% 2.27% 2.35% 2.37% 2.07% 2.56% 2.66% 2.83% 9.96% 10.19% 4.43% 2.61% <-Median-> 10 Dividends CND$
Yield on Cl 1.73% 1.44% 1.89% 2.21% 1.73% 1.66% 2.15% 1.98% 2.83% 7.37% 4.59% 3.18% 3.44% 3.44% 2.18% <-Median-> 10 Dividends CND$
Payout Ratio 25.4% 26.3% 24.3% 24.8% 30.7% 71.3% 93.5% 137.8% 93.2% 31.6% 77.8% 20.5% 32.0% 44.4% 51.45% <-Median-> 10 Dividends CND$
Payout Ratio CF 8.9% 9.6% 12.0% 25.7% 23.4% 21.0% 140.7% 306.7% -1661.8% 47.7% 49.2% 146.6% 48.7% 45.8% 36.69% <-Median-> 10 Dividends CND$
Average 5 Yrs Div Yd 6.06% 5 10.67% 10 Yield  3.57% 3.18% Payout 77.78% 49.17% 12.68% <-IRR #YR-> 10 Dividends CND$
* Dividends per share  12.0% Years 12.0% Years Last Div Inc ---> $0.59 $0.56 -5.1% 2.23% <-IRR #YR-> 5 Dividends CND$
-$0.17 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.56
-$0.50 $0.00 $0.00 $0.00 $0.00 $0.56
H/LYield held 5 yrs 3.37% 3.29% 4.13% 5.45% 4.93% 4.16% 4.78% 3.27% 2.57% 2.10% 4.13% <-Median-> 9 Dividends CND$
H/LYield held 10 yrs 6.51% 7.86% 7.31% 6.09% 4.64% 6.91% <-Median-> 4 Dividends CND$
Graham No. $9.33 $10.50 $13.58 $15.27 $12.18 $8.38 $8.75 $9.35 $10.00 $22.71 $12.69 $30.94 $26.10 $22.14 194.82% <-Total Growth 10 Graham Price CND$
Prem /Disc.Med H/L -13.76% -12.58% -11.28% -14.38% 17.83% 114.85% 148.32% 184.57% 181.34% -34.07% -24.10% -49.39% 3.28% <-Median-> 10 Graham Price CND$
Prem /Disc. High 4.84% 15.38% 1.49% -6.91% 35.98% 138.30% 173.17% 230.21% 270.56% 1.57% 6.35% -39.47% 21.17% <-Median-> 10 Graham Price CND$
Prem /Disc. Low -32.36% -40.55% -24.06% -21.85% -0.31% 91.40% 123.47% 138.94% 92.13% -69.71% -54.54% -59.31% -11.08% <-Median-> 10 Graham Price CND$
Prem /Disc to Cl -11.86% 11.76% -8.96% -16.80% 35.98% 138.30% 165.17% 220.68% 92.13% -59.06% 0.84% -43.25% -60.60% -36.27% 18.41% <-Median-> 10 Graham Price CND$
Closing  pre 05 $18.50
Closing  pre 07 $12.33
Price Cl CND$ $8.22 $11.73 $12.36 $12.70 $16.56 $19.97 $23.21 $29.97 $19.22 $9.30 $12.80 $17.56 $16.25 $16.25 49.70% <-Total Growth 10 Stock Price CND$
Increase 22.11% 42.66% 5.37% 2.75% 30.39% 20.59% 16.22% 29.13% -35.87% -51.61% 37.63% 37.19% -7.46% 0.00% 4.12% <-IRR #YR-> 10 Stock Price CND$
P/E 14.68 18.25 12.84 11.24 17.69 42.87 43.38 69.52 32.97 4.29 16.93 6.45 9.31 12.94 -5.43% <-IRR #YR-> 5 Stock Price CND$
Trailing P/E 17.79 20.95 19.23 13.19 14.65 21.33 49.82 56.02 44.58 15.95 5.91 23.22 5.97 9.31 7.24% <-IRR #YR-> 10 Price & Div CND$
Median 5 Yrs 2.86% 3.13% Div %  5, 10 yrs Price Inc 29.13% P/E: Y-T 16.93 23.22 -2.57% <-IRR #YR-> 5 Price & Div CND$
-$11.73 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $17.56
-$23.21 $0.00 $0.00 $0.00 $0.00 $17.56
-$11.73 $0.23 $0.28 $0.29 $0.33 $0.50 $0.59 $0.54 $0.69 $0.59 $18.12
-$23.21 $0.59 $0.54 $0.69 $0.59 $18.12
Price Cl US$ $4.61 $7.83 $7.64 $8.96 $12.76 $16.89 $19.61 $26.22 $19.25 $7.73 $12.12 $17.53 $16.61 $16.61 123.88% <-Total Growth 10 Stock Price US$
Increase 5.59% 69.85% -2.43% 17.28% 42.41% 32.37% 16.10% 33.71% -26.58% -59.84% 56.79% 44.64% -5.25% 0.00% 8.39% <-IRR #YR-> 10 Stock Price US$
P/E 12.13 18.54 12.64 12.52 17.61 43.68 42.63 70.86 32.63 4.37 16.83 6.42 9.49 13.18 -2.22% <-IRR #YR-> 5 Stock Price US$
Trailing P/E 15.38 20.60 18.09 14.82 17.83 23.31 50.72 57.00 52.03 13.10 6.85 24.35 6.08 9.49 11.64% <-IRR #YR-> 10 Price & Div US$
Median 5 Yrs 2.92% 3.25% Div %  5, 10 yrs Price Inc 33.71% P/E: Y-T 16.83 24.35 0.70% <-IRR #YR-> 5 Price & Div US$
-$7.83 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $17.53
-$19.61 $0.00 $0.00 $0.00 $0.00 $17.53
-$7.83 $0.15 $0.18 $0.22 $0.28 $0.43 $0.51 $0.55 $0.56 $0.56 $18.09
-$19.61 $0.51 $0.55 $0.56 $0.56 $18.09
Price H/L Med. CDN$ $8.05 $9.18 $12.05 $13.07 $14.35 $18.01 $21.74 $26.60 $28.15 $14.98 $9.64 $15.66 70.68% <-Total Growth 10 Stock Price CND$
Increase -7.79% 14.05% 31.28% 8.51% 9.79% 25.47% 20.72% 22.36% 5.83% -46.79% -35.66% 62.53% 5.49% <-IRR #YR-> 10 Stock Price CND$
P/E 14.37 14.27 12.51 11.56 15.33 38.65 40.63 61.69 48.28 6.91 12.74 5.75 -6.35% <-IRR #YR-> 5 Stock Price CND$
Trailing P/E 17.41 16.38 18.74 13.58 12.70 19.23 46.66 49.71 65.28 25.69 4.45 20.71 8.67% <-IRR #YR-> 10 Price & Div CND$
Median 5 Yrs 2.88% 3.17% Div %  5, 10 yrs Price Inc 5.83% P/E: Y-T 12.74 25.69 -3.47% <-IRR #YR-> 5 Price & Div CND$
-$9.18 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $15.66
-$21.74 $0.00 $0.00 $0.00 $0.00 $15.66
-$9.18 $0.15 $0.18 $0.22 $0.28 $0.43 $0.51 $0.55 $0.56 $0.56 $16.22
-$21.74 $0.51 $0.55 $0.56 $0.56 $16.22
Hi Mths CDN$ May Dec Aug Aug Dec Dec Aug Dec Feb Sep Dec Nov
Price Hi $9.78 $12.11 $13.78 $14.21 $16.56 $19.97 $23.91 $30.86 $37.07 $23.07 $13.50 $18.73 54.67% <-Total Growth 10 Stock Price CND$
Increase -10.19% 23.82% 13.79% 3.12% 16.54% 20.59% 19.73% 29.07% 20.12% -37.77% -41.48% 38.74% 4.46% <-IRR #YR-> 10 Stock Price CND$
P/E 17.46 18.84 14.31 12.57 17.69 42.87 44.69 71.58 63.59 10.65 17.86 6.88 -4.77% <-IRR #YR-> 5 Stock Price CND$
Trailing P/E 21.16 21.63 21.44 14.76 14.65 21.33 51.32 57.68 85.98 39.57 6.23 24.77
Median 5 Yrs Price Inc 20.12% P/E: Y-T 17.86 39.57
-$12.11 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $18.73
-$23.91 $0.00 $0.00 $0.00 $0.00 $18.73
Low Mths CDN$ Dec Feb Jan Jan Mar Jan Jan May Dec Nov Mar Jan
Price Low $6.31 $6.24 $10.31 $11.93 $12.14 $16.04 $19.56 $22.33 $19.22 $6.88 $5.77 $12.59 101.76% <-Total Growth 10 Stock Price CND$
Increase -3.81% -1.11% 65.22% 15.71% 1.76% 32.13% 21.95% 14.16% -13.93% -64.20% -16.13% 118.20% 7.27% <-IRR #YR-> 10 Stock Price CND$
P/E 11.27 9.71 10.71 10.55 12.97 34.43 36.56 51.79 32.97 3.18 7.63 4.63 -8.43% <-IRR #YR-> 5 Stock Price CND$
Trailing P/E 13.65 11.14 16.04 12.39 10.74 17.13 41.99 41.74 44.58 11.80 2.66 16.65
Median 5 Yrs Price Inc -13.93% P/E: Y-T 7.63 16.65
-$6.24 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $12.59
Market Cap CDN$ $2,455 $4,190 $4,496 $4,582 $5,822 $6,991 $8,050 $11,895 $7,550 $3,637 $6,417 $8,827 $8,185 $8,185 $10.500 0.13% Market Cap CND$
# of Sh in M 298.6 357.2 363.8 360.8 351.6 350.1 346.8 396.9 392.8 391.1 501.4 502.7 503.7 503.7 Common Equity Shares
Increase -0.28% 19.63% 1.85% -0.81% -2.57% -0.41% -0.94% 14.44% -1.03% -0.43% 28.19% 0.27% 0.20% 0.00% 3.85% <-Average 10
CF fr Op US $M $323.1 $415.0 $444.0 $250.0 $334.0 $459.0 $106.0 $66.0 -$13.0 $459.0 $571.0 $192.0 $579.3 $579.3 -53.73% <-Total Growth 10 Cash Flow US$
OPS (per share) US$ $1.08 $1.16 $1.22 $0.69 $0.95 $1.31 $0.31 $0.17 -$0.03 $1.17 $1.14 $0.38 $1.15 $1.15 -67.13% <-Total Growth 10 Cash Flow US$
CF fr Op CDN $M 476.0 $631.8 $707.1 $394.9 $431.7 $553.0 $123.3 $76.9 -$12.8 $561.8 $599.6 $191.4 $577.5 $577.5 -69.70% <-Total Growth 10 Cash Flow CND$
OPS (per share) CDN$ $1.59 $1.77 $1.94 $1.09 $1.23 $1.58 $0.36 $0.19 -$0.03 $1.44 $1.20 $0.38 $1.15 $1.22 -78.47% <-Total Growth 10 Cash Flow CND$
Non-Cash CF US$ $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $61.0 $94.0 -$94.0 $64.0 $204.0 -14.24% <-IRR #YR-> 10 Cash Flow CND$
Non-Cash CF CDN$ $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $0.0 $71.1 $92.9 -$115.1 $67.2 $203.4 1.39% <-IRR #YR-> 5 Cash Flow CND$
OPS non-cash $1.59 $1.77 $1.94 $1.09 $1.23 $1.58 $0.36 $0.37 $0.20 $1.14 $1.33 $0.79 $1.15 $1.22 -7.80% <-IRR #YR-> 10 CF - non cash CND$
P/CF on Cl 5.16 6.63 6.36 11.60 13.49 12.64 65.30 80.38 94.33 8.14 9.62 22.36 14.17 13.32 17.18% <-IRR #YR-> 5 CF - non cash CND$
*Operational Cash Flow per share P/CF 10 yr 13.06 5 yr  22.36
-$1.77 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.38
-$0.36 $0.00 $0.00 $0.00 $0.00 $0.38
-$1.77 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.79
-$0.36 $0.00 $0.00 $0.00 $0.00 $0.79
OPM CDN$ 17.49% 19.76% 19.47% 18.22% 24.50% 31.83% 6.84% 3.45% -0.45% 16.36% 21.34% 14.48% 28.05% should be zero, it is a check on calculations CND$
Diff from Ave 1.2% 14.3% 12.6% 5.4% 41.7% 84.1% -60.4% -80.0% -102.6% -5.4% 23.4% -16.3% 62.2% 0.00 <-Median-> 10 OPM CND$
*Operational Profit Margin (CF/Revenue) Ratio OPM 10 Yrs 17.29% 5 Yrs 14.48%
Q2 2011
Assets US$ $8,624 $8,076 $5,661 $8,097 $8,800 $9,513 $19,314 $20,473 $19,457 $20,570 $20,420 $20,757 A/L ratio of 1.5 and up, best Assets US$
Liab. $6,837 $6,132 $3,568 $5,100 $6,435 $7,182 $15,550 $16,734 $15,437 $14,806 $10,350 $9,690 1.35 <-Median-> 10 Liabilities US$
Liquidity 1.26 1.32 1.59 1.59 1.37 1.32 1.24 1.22 1.26 1.39 1.97 2.14 1.26 <-Median-> 5 Ratio US$
Assets CDN$ $11,712 $13,129 $12,862 $8,942 $10,465 $10,602 $11,064 $22,505 $20,229 $23,815 $21,601 $20,359 $20,695 A/L ratio of 1.5 and up, best Assets CND$
Liab. $9,650 $10,409 $9,766 $5,636 $6,591 $7,753 $8,353 $18,119 $16,535 $18,895 $15,548 $10,319 $9,661 1.35 <-Median-> 10 Liabilities CND$
Liquidity 1.21 1.26 1.32 1.59 1.59 1.37 1.32 1.24 1.22 1.26 1.39 1.97 2.14 1.26 <-Median-> 5 Ratio CND$
Total Equity US$ $2,997 $2,365 $2,331 $3,764 $3,739 $4,020 $5,764 $10,070 $11,067
Preferred Equity US$ $246 $246 $585 $579 $1,001 $365 $374 $371 $427 $358 $667 $848 $848 Preferred Eq US$
Non-Control. Int US$ $0 $0 $0 $0 $81 $53 $59 $326 $279 $280 $575 $1,339 $1,454 Non-Control. US$
Book Value US$ $1,400 $1,787 $1,944 $2,093 $1,915 $1,947 $1,898 $3,067 $3,033 $3,382 $4,522 $7,883 $8,765 341.13% <-Total Growth 10 Book Value US$
$0 $1,787 $1,944 $2,093 $1,947
Total Equity $3,873 $2,849 $2,711 $4,386 $3,695 $4,920 $6,053 $10,040 $11,034
Preferred Equity $362 $375 $932 $915 $1,294 $440 $435 $432 $422 $438 $700 $845 $845 Preferred Eq CND$
Non-Control. Int $0 $0 $0 $0 $105 $64 $69 $380 $276 $343 $604 $1,335 $1,450 Non-Control. CND$
B VCDN$ Ck $2,062 $2,721 $3,096 $3,306 $2,475 $2,346 $2,207 $3,574 $2,997 $4,140 $4,749 $7,859 $8,739
Book Value CDN$ $2,062 $2,721 $3,096 $3,306 $2,475 $2,346 $2,207 $3,574 $2,997 $4,140 $4,749 $7,859 $8,739 188.89% <-Total Growth 10 Book Value CND$
BV per share $6.91 $7.62 $8.51 $9.16 $7.04 $6.70 $6.36 $9.00 $7.63 $10.58 $9.47 $15.63 $17.35 $17.35 105.26% <-Total Growth 10 Book Value CND$
Change 6.21% 10.28% 11.74% 7.66% -23.17% -4.83% -5.01% 41.47% -15.26% 38.72% -10.51% 65.07% 10.97% 0.4924 Current/Historical Book Value CND$
P/BV (CL) 1.19 1.54 1.45 1.39 2.35 2.98 3.65 3.33 2.52 0.88 1.35 1.12 0.94 7.46% <-IRR #YR-> 10 BV per share CND$
Change 14.97% 29.36% -5.70% -4.56% 69.71% 26.71% 22.35% -8.72% -24.32% -65.12% 53.80% -16.89% -16.61% 19.69% <-IRR #YR-> 5 BV per share CND$
Leverage (A/BK) 5.68 4.83 4.15 2.70 4.23 4.52 5.01 6.30 6.75 5.75 4.55 2.59 2.37 4.53 <-Median-> 10 A/BV CND$
Debt/Equity Ratio 4.68 3.83 3.15 1.70 2.66 3.31 3.78 5.07 5.52 4.56 3.27 1.31 1.11 3.29 <-Median-> 10 Debt/Eq Ratio CND$
Sharerholders Equity (Assets less liabilities) P/BV 10 yr Ave 1.90 5 yr Ave 1.35
-$7.62 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $15.63
-$6.36 $0.00 $0.00 $0.00 $0.00 $15.63
ROE 8534.2% 22886.3% 47682.8% 8.4% 23.5% 29.0% <-12 mths 8534.22% <-Median-> 5 Compreh. Inc US$
Comprehensive Inc $106 $280 $601 $379 $1,855 $2,539 <-12 mths Compreh. Inc US$
ROE 3.5% 9.2% 17.8% 8.4% 23.5% 29.0% <-12 mths 9.23% <-Median-> 5 Compreh. Inc CND$
Comprehensive Inc $124 $277 $736 $398 $1,849 $2,531 <-12 mths Compreh. Inc CND$
ROE 11.1% 9.5% 12.4% 13.4% 14.6% 7.1% 8.6% 4.4% 7.9% 20.7% 7.0% 21.4% 26.0% <-12 mths Net Income/Shareholders' equity ROE CND$
5Yr Running Ave 8.1% 9.7% 11.4% 12.3% 11.6% 11.5% 9.5% 8.2% 10.5% 10.0% 14.0% 18.9% <-12 mths ROE CND$
Net Income US$ $170 $241 $280 $279 $138 $164 $135 $240 $700 $317 $1,686 $2,276 <-12 mths 891.76% <-Total Growth 10 Net Income US$
Oper C. F. $415 $444 $250 $334 $459 $106 $66 -$13 $459 $571 $192 -$12 <-12 mths C F Statement  Oper C. F.
Invest. C. F -$411 -$180 -$407 -$108 -$264 -$222 $6,055 -$347 -$103 -$1,041 -$1,067 -$428 <-12 mths C F Statement  Invest. C. F US$
Total Accruals $166 -$23 $437 $53 -$57 $280 -$5,986 $600 $344 $787 $2,561 $2,716 <-12 mths Accruals US$
Total Assets $8,624 $8,076 $5,661 $8,097 $8,800 $9,513 $19,314 $20,473 $19,457 $20,570 $20,420 $20,757 <-12 mths Balance Sheet Assets US$
Accruals Ratio 1.92% -0.28% 7.72% 0.65% -0.65% 2.94% -30.99% 2.93% 1.77% 3.83% 12.54% 13.08% <-12 mths Ratio
Net Income CDN$ $228 $259 $384 $442 $361 $166 $191 $157 $237 $857 $333 $1,681 $2,269 <-12 mths 549.50% <-Total Growth 10 Net Income CND$
Oper C. F. $476 $632 $707 $395 $432 $553 $123 $77 -$13 $562 $600 $191 -$12 <-12 mths C F Statement  Oper C. F.
Invest. C. F -$259 -$626 -$287 -$643 -$140 -$318 -$258 $7,055 -$343 -$126 -$1,093 -$1,064 -$427 <-12 mths C F Statement  Invest. C. F CND$
Total Accruals $11 $253 -$37 $690 $68 -$69 $326 -$6,975 $593 $421 $826 $2,553 $2,708 <-12 mths Accruals CND$
Total Assets $11,712 $13,129 $12,862 $8,942 $10,465 $10,602 $11,064 $22,505 $20,229 $23,815 $21,601 $20,359 $20,695 <-12 mths Balance Sheet Assets CND$
Accruals Ratio 0.09% 1.92% -0.28% 7.72% 0.65% -0.65% 2.94% -30.99% 2.93% 1.77% 3.83% 12.54% 13.08% <-12 mths Ratio CND$
up/down/neutral
Chge in Close 22.11% 42.66% 5.37% 2.75% 30.39% 20.59% 16.22% 29.13% -35.87% -51.61% 37.63% 37.19% -7.46% CND$
Any Predictions?
Fin. C. F US$ -$12 -$277 -$275 $129 -$215 $68 $6,113 $386 -$413 $489 $913 $475 <-12 mths C F Statement  Fin. C. F US$
Total Accruals $178 $254 $712 -$76 $158 $212 -$12,099 $214 $757 $298 $1,648 $2,241 <-12 mths Accruals US$
Accruals Ratio 2.06% 3.15% 12.58% -0.94% 1.80% 2.23% -62.64% 1.05% 3.89% 1.45% 8.07% 10.80% <-12 mths Ratio US$
Fin. C. F $CDN -$105 -$18 -$441 -$434 $167 -$259 $79 $7,123 $381 -$506 $514 $910 $474 <-12 mths C F Statement  Fin. C. F CND$
Total Accruals $116 $271 $405 $1,125 -$98 $190 $247 -$14,098 $211 $927 $313 $1,643 $2,234 <-12 mths Accruals CND$
Accruals Ratio 0.99% 2.06% 3.15% 12.58% -0.94% 1.80% 2.23% -62.64% 1.05% 3.89% 1.45% 8.07% 10.80% <-12 mths Ratio CND$
Aug 20, 2011.  Last I looked I got estimates for 2010 and 2011 of $.90 and $.91 US$ for earnings and $1.62 and $2.00 for CF US$.
Brookfield has adopted International Financial Reporting Standards (IFRS). CANNOT RESOLVE CHANGE IN EQUITY, so leaving updated to end of financial year 2010.
effective Q1/10.  Please note that their 2010 and 2011 estimates reflect IFRS while our historical data block is presented under historical GAAP.
Jun 05, 2010.  When I last looked at this stock I could estimates for 2009 and 2010 of $.39 and $.30 US$ for earnings and $1.42 and $1.33 for CF US$.
May 23, 2009 AR 2008. In Nov 2008, I got estimates of $.60 US$ earnings  for 2008. Earnings came in at $1.77 US$
History
This stock was at least at $16.89 in 1989.  Stock recovered in 1896 and 1897,  however, it did not surpass the values of 1989 until 2004, 15 years later.
How they make their money.
Brookfield Properties is a leading North American commercial real estate company that invests in premier-quality office properties in high-growth markets driven by financial service, government, 
and energy tenants.  The portfolio is composed of office properties in 12 top U.S. and Canadian markets.
For most ratios, lower is better when looking for a good stock price.  However, there are exceptions such as for yield and asset/liability ratios and here you want a higher ratios to indicate a good stock price.  
Also, for the Operational Profit Margin, a higher percentage is better.  With the OPM, you should only compare companies in similar industries.
Copyright © 2008 Website of SPBrunner. All rights reserved.
Institutional Holders 488.796 97.04%
0.257 0.05%
488.540